ABSOLUTE Q Trademark

Trademark Overview


On Tuesday, August 10, 2021, a trademark application was filed for ABSOLUTE Q with the United States Patent and Trademark Office. The USPTO has given the ABSOLUTE Q trademark a serial number of 90875316. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, September 4, 2024. This trademark is owned by Combinati Incorporated. The ABSOLUTE Q trademark is filed in the Pharmaceutical Products category with the following description:

Kits consisting primarily of medical diagnostic reagents and laboratory equipment being microfluidic array plates for medical use; clinical medical diagnostic reagents being oligonucleotides, primers, enzymes and reaction buffers, sold individually, for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription-polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications; medical diagnostic kits consisting primarily of clinical medical reagents being oligonucleotides, enzymes, and nucleotides, and also containing DNA primers and biochemical probes, fluorescent reference dye, and reaction buffers for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applicat...
absolute q

General Information


Serial Number90875316
Word MarkABSOLUTE Q
Filing DateTuesday, August 10, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements


Goods and ServicesKits consisting primarily of medical diagnostic reagents and laboratory equipment being microfluidic array plates for medical use; clinical medical diagnostic reagents being oligonucleotides, primers, enzymes and reaction buffers, sold individually, for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription-polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications; medical diagnostic kits consisting primarily of clinical medical reagents being oligonucleotides, enzymes, and nucleotides, and also containing DNA primers and biochemical probes, fluorescent reference dye, and reaction buffers for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCombinati Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306

Party NameCombinati Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306

Trademark Events


Event DateEvent Description
Friday, August 13, 2021NEW APPLICATION ENTERED
Friday, October 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 10, 2022ASSIGNED TO EXAMINER
Tuesday, May 10, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 10, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 7, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 7, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, June 7, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 7, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, June 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 3, 2023SOU EXTENSION 1 FILED
Friday, March 3, 2023SOU EXTENSION 1 GRANTED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 9, 2023TEAS REQUEST TO DIVIDE RECEIVED
Thursday, March 9, 2023DIVISIONAL REQUEST RECEIVED
Monday, April 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 3, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, April 20, 2023CORRECTED NOA E-MAILED
Wednesday, September 6, 2023SOU EXTENSION 2 FILED
Wednesday, September 6, 2023SOU EXTENSION 2 GRANTED
Friday, September 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 6, 2024SOU EXTENSION 3 FILED
Wednesday, September 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 6, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 6, 2024SOU EXTENSION 3 GRANTED
Thursday, March 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU EXTENSION 4 FILED
Wednesday, September 4, 2024SOU EXTENSION 4 GRANTED